Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Pain 1Neoplasms 1Hyperalgesia 1

Interventions

Bupivacaine 4Analgesia 4Ropivacaine 3Morphine 3Ketamine 3Sufentanil 2Psychiatric Rehabilitation 2Oxycodone 2Methadone 2Lidocaine 2Ketorolac 2Hydromorphone 2Fentanyl 2Esketamine 2Epinephrine 2Docetaxel 2Dexmedetomidine 2Control Groups 2Acetaminophen 2ziconotide 1tanezumab 1parecoxib 1nabiximols 1loxoprofen 1Whole Body Imaging 1Vertebroplasty 1Tramadol 1Therapeutics 1Telemedicine 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pain × Amantadine × Clear all
NCT00188383 2006-03-14

Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy

University Health Network, Toronto

Phase 1/2 Unknown
132 enrolled
Genitourinary

Hyperalgesia, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡